LSEGBX
Shield Therapeutics plc STX
- Market cap
- GBP 58.4M
Key Data
- Market cap
- GBP 58.4M
- EPS
- GBP −0.01
- 52 weeks
- 3.7012.20
- 1-year return
- −26.02%
- Avg. volume (200d)
- 2.3M
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Technical Signals
Technical signals
Only our Plus members can access this area.
AI Models
AI models
Only our Plus members can access this area.
About Shield Therapeutics Plc
Market capitalization is 58.4M GBP, earnings per share −0.01 GBP, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry. The 52-week range is 3.70 – 12.20 GBX; the one-year return is −26.02%.
Frequently Asked Questions
What is the STX stock price today?
Price data for STX is temporarily unavailable and will refresh with the next update.
What are the P/E ratio and market cap of STX?
STX trades at a price-to-earnings ratio of —, with earnings per share of −0.01 GBP and a market capitalization of 58.4M GBP. Ratios use the latest reported results and the current price.
What is the 52-week range of STX?
Over the past 52 weeks STX traded between 3.70 and 12.20 GBX; the one-year return is −26.02%.
Does STX pay a dividend?
The current dividend yield of STX is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.
What sector is Shield Therapeutics plc in?
Shield Therapeutics plc (STX) is listed on the London Stock Exchange; its sector is Healthcare and its industry is Drug Manufacturers - Specialty & Generic.
Where does the data on this page come from and how fresh is it?
Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.